Novavax says Phase 3 trial of omicron-targeting COVID vaccine supports its use as a booster
Novavax Inc. NVAX, -1.88% said Tuesday a late-stage trial of its vaccine targeting the COVID…
Read MoreNovavax Inc. NVAX, -1.88% said Tuesday a late-stage trial of its vaccine targeting the COVID…
Read MoreNo one won Powerball yet, but some folks are still having a ball. While lottery…
Read MoreAmericans who hadn’t voted early in the midterm elections were heading to the polls on…
Read MoreOfficials in Germany on Tuesday were searching Munich and Frankfurt offices of Swiss banking giant…
Read MoreThe 2-year Treasury yield on Tuesday edged down from its highest level in more than…
Read MoreThe S&P 500 SPX, +0.96% is trading at roughly the same level from five months…
Read MoreAMC Entertainment Holdings Inc.’s stock rose 2.4% before the opening bell on Tuesday, lifted by…
Read MorePuma SE said Tuesday that Arne Freundt will take over immediately as chief executive, ahead…
Read MoreOil futures lost ground Tuesday as investors remained uncertain about the outlook for crude demand…
Read More
Semiconductor stocks have bounced from 2022 lows — and analysts expect upside of at least 28% in the next year
For investors aiming to take advantage of stock market declines, the obvious question is: How…
Read More